Altimmune's Grant - II Round

Altimmune raised a round of funding on June 18, 2001. Investors include National Institute of Allergy and Infectious Diseases.

Altimmune, formerly Vaxin, is an immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases.…

Articles about Altimmune's Grant - II Round: